Cambridge Healthtech Institute’s 4th Annual

Improving Immunotherapy Efficacy and Safety
( 改善免疫疗法有效性及安全性 )



Immunotherapies represent a step-change in cancer treatment, yet questions still remain around their efficacy, targeting and toxicity. Cambridge Healthtech Institute’s Improving Immunotherapy Efficacy and Safety conference details the latest developments in immunotherapy, including established and emerging targets and modalities, new engineering strategies, combinations, biomarkers, effective preclinical models and strategies to mitigate toxicity and recent clinical developments. Examples will come from the world of checkpoint inhibitors, adoptive T cell therapy, combinations and oncolytic viruses. We will also investigate manipulating the tumor microenvironment and emerging IO targets.


Coverage will include, but is not limited to:


  • Predicting immunotherapy activity and outcome
  • Emerging targets
  • Latest immunotherapy engineering strategies
  • Turning cold tumors into hot tumors
  • Understanding tumor microenvironment
  • Biomarkers for tumor microenvironment
  • Identifying patient responders
  • Monitoring therapies in real time
  • Manipulating the tumor microenvironment to predict and monitor therapies
  • Combined immune checkpoint blocking antibodies plus targeted therapy
  • Biomarker strategies for combination therapies
  • New technologies to prevent, control and mitigate toxicology
  • Cytokine storm, cytokine response, macrophage activation syndrome


* 活动内容有可能不事先告知作更动及调整。

Choose your language